This announcement is a separate document:
第一工業製薬：2025年３月期第２四半期連結累計期間及び通期連結業績予想の修正並びに配当予想の修正に関するお知らせ
DKS: Notice regarding revisions to consolidated earnings forecasts for the 2nd quarter and full-year consolidated earnings forecasts for the fiscal year ending March 31, 2025, and revisions to dividend forecasts
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.